Clinical Trial Update: PPI Versus Histamine Antagnists as Adjuvant to Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing proton pump inhibitors versus histamine antagonists as an adjuvant to chemotherapy for lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Lymphoma | Phase 3 | Status: RECRUITING